LYEL
Lyell Immunopharma Inc
9.70$
-1.1%
vs. previous close
Closing price · As of: Sep 28, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| 0.05 | 0.63 | 0.88 | 6.85 | 0.01 | 0.00 | 0.00 | |
| – | 0.61 | 1.20 | 1.33 | 1.61 | – | 0.68 | |
| 0.05 | 0.63 | 0.88 | 6.85 | 0.01 | 0.00 | -0.67 | |
| 5.16 | 14.78 | 11.43 | 12.89 | 14.58 | 13.13 | 9.28 | |
| 3.18 | 3.80 | 7.34 | 9.50 | 5.34 | 3.98 | 2.64 | |
| 8.33 | 17.82 | 18.57 | 22.00 | 19.69 | 27.45 | 11.25 | |
| -8.28 | -17.19 | -17.70 | -15.14 | -19.68 | -27.44 | -11.92 | |
| 0.00 | 0.48 | 0.10 | – | – | – | – | |
| -10.49 | -16.58 | -20.62 | -14.82 | -18.70 | -26.23 | -16.06 | |
| -0.66 | -0.48 | 2.91 | -14.44 | -0.84 | – | – | |
| -10.49 | -16.58 | -20.62 | -14.82 | -18.70 | -26.23 | -16.06 | |
| -8.18 | -17.47 | -19.49 | -13.36 | -17.08 | -15.35 | -15.38 |
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.